Fertilit\u00e9<\/p>[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/humainhealthcare.com\/wp-content\/uploads\/2025\/04\/fertility-barcelona-scaled.jpg” title_text=”fertility-barcelona” force_fullwidth=”on” _builder_version=”4.27.4″ _module_preset=”default” height=”500px” height_tablet=”” height_phone=”auto” height_last_edited=”on|phone” border_radii=”on|3px|3px|3px|3px” box_shadow_style=”preset1″ box_shadow_color=”rgba(0,0,0,0.03)” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”off|desktop” _builder_version=”4.27.4″ _module_preset=”default” background_enable_color=”off” background_image=”https:\/\/humainhealthcare.com\/wp-content\/uploads\/2025\/04\/fertility-barcelona-scaled.jpg” background_size=”stretch” custom_margin=”||||false|false” custom_margin_tablet=”0px||||false|false” custom_margin_phone=”0px||||false|false” custom_margin_last_edited=”on|tablet” custom_padding_tablet=”0px||0px||false|false” custom_padding_phone=”30px||30px||false|false” locked=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” custom_padding=”0px||0px||true|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_divider show_divider=”off” _builder_version=”4.27.4″ _module_preset=”default” custom_padding=”315px||315px||true|false” custom_padding_tablet=”150px||150px||true|false” custom_padding_phone=”80px||80px||true|false” custom_padding_last_edited=”on|phone” global_colors_info=”{}”][\/et_pb_divider][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.27.4″ _module_preset=”default” custom_padding=”||0px||false|false” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” custom_padding=”||0px||false|false” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font=”Unna||||||||” text_text_color=”#042C54″ text_font_size=”28px” text_line_height=”1.6em” link_text_color=”#042C54″ ul_line_height=”1.6em” header_2_font=”Unna|700|||on|||#000000|” header_2_text_color=”#000000″ header_4_font=”Unna|700|||||||” header_4_text_color=”#000080″ header_4_font_size=”30px” header_4_letter_spacing=”1px” custom_margin=”||||false|false” custom_margin_tablet=”||||false|false” custom_margin_phone=”||||false|false” custom_margin_last_edited=”on|phone” hover_enabled=”0″ text_font_size_tablet=”26px” text_font_size_phone=”20px” text_font_size_last_edited=”on|phone” header_4_font_size_tablet=”30px” header_4_font_size_phone=”26px” header_4_font_size_last_edited=”on|phone” locked=”off” global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″]
La pr\u00e9servation de la fertilit\u00e9 par vitrification des ovules est une proc\u00e9dure qui permet aux femmes de congeler et de stocker leurs ovules pour une utilisation ult\u00e9rieure.<\/p>\n
Ceci est utile pour celles qui souhaitent reporter la naissance d\u2019un enfant pour des raisons sociales ou m\u00e9dicales.<\/p>\n
Les ovules congel\u00e9s peuvent \u00eatre d\u00e9congel\u00e9s et f\u00e9cond\u00e9s ult\u00e9rieurement pour obtenir une grossesse.<\/p>\n
Ce traitement permet de retarder la maternit\u00e9 sans que le passage du temps ne porte pr\u00e9judice aux possibilit\u00e9s futures de devenir m\u00e8re, car la d\u00e9t\u00e9rioration de la qualit\u00e9 des ovocytes fait qu'\u00e0 partir de 35 ans les chances de grossesse subissent une diminution notable.<\/p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font=”Unna|700||on|||||” text_text_color=”#000080″ text_font_size=”42px” text_line_height=”1.2em” hover_enabled=”0″ text_font_size_tablet=”30px” text_font_size_phone=”30px” text_font_size_last_edited=”on|phone” global_colors_info=”{}” module_id=”Artificial” sticky_enabled=”0″]
Ins\u00e9mination artificielle avec le sperme du partenaire<\/p>[\/et_pb_text][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font=”Unna||||||||” text_text_color=”#000000″ text_font_size=”26px” text_line_height=”1.6em” header_4_font=”Unna|700|||||||” header_4_text_color=”#000000″ header_4_font_size=”21px” custom_margin=”||||false|false” custom_margin_tablet=”||||false|false” custom_margin_phone=”||||false|false” custom_margin_last_edited=”on|phone” text_font_size_tablet=”26px” text_font_size_phone=”20px” text_font_size_last_edited=”on|phone” global_colors_info=”{}”]
L'ins\u00e9mination artificielle avec sperme du partenaire est une proc\u00e9dure de procr\u00e9ation assist\u00e9e qui consiste \u00e0 introduire le sperme du partenaire masculin dans l'ut\u00e9rus de la femme pendant l'ovulation, dans le but de faciliter la f\u00e9condation de l'ovule.<\/p>\n
Cette proc\u00e9dure est utilis\u00e9e lorsqu'il y a des difficult\u00e9s \u00e0 concevoir naturellement, mais lorsque le sperme du partenaire n'est pas gravement alt\u00e9r\u00e9.<\/p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font=”Unna|700||on|||||” text_text_color=”#000080″ text_font_size=”42px” text_line_height=”1.2em” hover_enabled=”0″ text_font_size_tablet=”30px” text_font_size_phone=”30px” text_font_size_last_edited=”on|phone” global_colors_info=”{}” module_id=”Donor” sticky_enabled=”0″]
Ins\u00e9mination artificielle avec sperme de donneur<\/p>[\/et_pb_text][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font=”Unna||||||||” text_text_color=”#000000″ text_font_size=”26px” text_line_height=”1.6em” header_4_font=”Unna|700|||||||” header_4_text_color=”#000000″ header_4_font_size=”21px” custom_margin=”||||false|false” custom_margin_tablet=”||||false|false” custom_margin_phone=”||||false|false” custom_margin_last_edited=”on|phone” text_font_size_tablet=”26px” text_font_size_phone=”20px” text_font_size_last_edited=”on|phone” global_colors_info=”{}”]
L'ins\u00e9mination artificielle avec sperme de donneur (IAS) est une proc\u00e9dure de procr\u00e9ation assist\u00e9e dans laquelle le sperme d'un donneur est introduit dans l'ut\u00e9rus de la femme pour faciliter la f\u00e9condation de l'ovule.<\/p>\n
Cette proc\u00e9dure est id\u00e9ale pour les femmes confront\u00e9es \u00e0 la monoparentalit\u00e9, les couples de femmes ou les couples h\u00e9t\u00e9rosexuels o\u00f9 l'homme a de graves probl\u00e8mes de fertilit\u00e9 et nous devons recourir au sperme d'un donneur.<\/p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font=”Unna|700||on|||||” text_text_color=”#000080″ text_font_size=”42px” text_line_height=”1.2em” hover_enabled=”0″ text_font_size_tablet=”30px” text_font_size_phone=”30px” text_font_size_last_edited=”on|phone” global_colors_info=”{}” module_id=”Vitro” sticky_enabled=”0″]
F\u00e9condation in vitro (FIV)<\/p>[\/et_pb_text][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font=”Unna||||||||” text_text_color=”#000000″ text_font_size=”26px” text_line_height=”1.6em” header_4_font=”Unna|700|||||||” header_4_text_color=”#000000″ header_4_font_size=”21px” custom_margin=”||||false|false” custom_margin_tablet=”||||false|false” custom_margin_phone=”||||false|false” custom_margin_last_edited=”on|phone” text_font_size_tablet=”26px” text_font_size_phone=”20px” text_font_size_last_edited=”on|phone” global_colors_info=”{}”]
La f\u00e9condation in vitro (FIV) est une technique de reproduction assist\u00e9e qui consiste \u00e0 ins\u00e9miner des ovules avec des spermatozo\u00efdes en laboratoire, g\u00e9n\u00e9rant des embryons qui sont ensuite transf\u00e9r\u00e9s dans l'ut\u00e9rus.<\/p>\n
Ce traitement a un taux de r\u00e9ussite variable selon l\u2019\u00e2ge et les caract\u00e9ristiques des femmes ou des couples.<\/strong><\/p>\n Il est recommand\u00e9 aux couples ayant des difficult\u00e9s \u00e0 concevoir naturellement et peut\u00a0aider \u00e0 surmonter les probl\u00e8mes de fertilit\u00e9 tant pour les hommes que pour les femmes.<\/strong><\/p>\n L'objectif de ce traitement est d'obtenir des embryons qui serviront ult\u00e9rieurement \u00e0 cr\u00e9er une grossesse. Le processus commence par une stimulation ovarienne suivie d'un pr\u00e9l\u00e8vement d'ovules. Ces ovules sont f\u00e9cond\u00e9s en laboratoire avec le sperme du partenaire ou d'un donneur, g\u00e9n\u00e9rant ainsi des embryons. Les embryons sont ensuite cultiv\u00e9s jusqu'\u00e0 atteindre un stade de d\u00e9veloppement embryonnaire appel\u00e9 blastocyste. Ce stade est g\u00e9n\u00e9ralement atteint 5 \u00e0 6 jours apr\u00e8s la f\u00e9condation.<\/p>\n Une fois le stade blastocyste atteint, l'embryon de meilleure qualit\u00e9 est g\u00e9n\u00e9ralement s\u00e9lectionn\u00e9 pour \u00eatre transf\u00e9r\u00e9 dans l'ut\u00e9rus de la femme. Ce transfert, appel\u00e9 \u00ab transfert frais \u00bb, est r\u00e9alis\u00e9 5 jours apr\u00e8s le pr\u00e9l\u00e8vement des ovules. S'il reste des embryons, ils seront congel\u00e9s pour d'autres tentatives de grossesse.<\/p>\n Dans certaines circonstances (r\u00e9ponse \u00e9lev\u00e9e, endom\u00e8tre r\u00e9fractaire, pr\u00e9sence de polypes, asynchronie embryon\/endom\u00e8tre\u2026), il peut \u00eatre indiqu\u00e9 de congeler tous les embryons et de diff\u00e9rer le transfert du premier embryon.<\/p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font=”Unna|700||on|||||” text_text_color=”#000080″ text_font_size=”42px” text_line_height=”1.2em” text_font_size_tablet=”30px” text_font_size_phone=”30px” text_font_size_last_edited=”on|phone” global_colors_info=”{}”] FIV naturelle<\/p>[\/et_pb_text][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font=”Unna||||||||” text_text_color=”#000000″ text_font_size=”26px” text_line_height=”1.6em” header_4_font=”Unna|700|||||||” header_4_text_color=”#000000″ header_4_font_size=”21px” custom_margin=”||||false|false” custom_margin_tablet=”||||false|false” custom_margin_phone=”||||false|false” custom_margin_last_edited=”on|phone” text_font_size_tablet=”26px” text_font_size_phone=”20px” text_font_size_last_edited=”on|phone” global_colors_info=”{}”] La FIV naturelle est un type de f\u00e9condation in vitro qui utilise la maturation monofolliculaire naturelle r\u00e9alis\u00e9e par le propre cycle de la femme,\u00a0sans avoir besoin de stimulation ovarienne au moyen de m\u00e9dicaments.<\/strong><\/p>\n Ce traitement est indiqu\u00e9 chez les femmes ayant une faible r\u00e9serve ovarienne, cas dans lesquels les m\u00e9dicaments ne peuvent pas aider \u00e0 g\u00e9n\u00e9rer plus d\u2019ovocytes.<\/p>\n Il est utile aux couples qui ont des difficult\u00e9s \u00e0 concevoir naturellement,\u00a0aidant \u00e0 surmonter les probl\u00e8mes de fertilit\u00e9 masculine et f\u00e9minine.<\/strong><\/p>\n La FIV naturelle est un traitement de fertilit\u00e9 r\u00e9alis\u00e9 sans stimulation ovarienne m\u00e9dicamenteuse. Elle est recommand\u00e9e aux femmes ayant une r\u00e9serve ovarienne tr\u00e8s faible, car l'administration de m\u00e9dicaments n'augmentera pas le nombre d'ovules disponibles. L'objectif est d'obtenir un seul ovocyte issu du cycle naturel de la femme.<\/p>\n Le processus commence par la surveillance du cycle menstruel par \u00e9chographie, sans traitement m\u00e9dicamenteux. Lorsque l'ovule atteint sa maturit\u00e9, l'ovulation est induite et l'ovule est extrait par ponction ovarienne.<\/p>\n \u00c0 partir de l'ovocyte pr\u00e9lev\u00e9, le laboratoire cr\u00e9e des embryons qui sont cultiv\u00e9s jusqu'au stade de blastocyste, g\u00e9n\u00e9ralement 5 \u00e0 6 jours apr\u00e8s la f\u00e9condation. Si l'embryon atteint ce stade, il est transf\u00e9r\u00e9 dans l'ut\u00e9rus de la femme.<\/p>[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font=”Unna|700||on|||||” text_text_color=”#000080″ text_font_size=”42px” text_line_height=”1.2em” text_font_size_tablet=”30px” text_font_size_phone=”30px” text_font_size_last_edited=”on|phone” global_colors_info=”{}”] FIV douce<\/p>[\/et_pb_text][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font=”Unna||||||||” text_text_color=”#000000″ text_font_size=”26px” text_line_height=”1.6em” header_4_font=”Unna|700|||||||” header_4_text_color=”#000000″ header_4_font_size=”21px” custom_margin=”||||false|false” custom_margin_tablet=”||||false|false” custom_margin_phone=”||||false|false” custom_margin_last_edited=”on|phone” text_font_size_tablet=”26px” text_font_size_phone=”20px” text_font_size_last_edited=”on|phone” global_colors_info=”{}”] La FIV douce est un type de f\u00e9condation in vitro dans lequel\u00a0la stimulation ovarienne est r\u00e9alis\u00e9e avec de faibles doses de m\u00e9dicaments<\/strong>, afin que le cycle naturel de la femme soit davantage respect\u00e9.<\/p>\n Il est indiqu\u00e9 chez les femmes ayant une faible r\u00e9serve ovarienne, cas dans lesquels l'utilisation de doses \u00e9lev\u00e9es de m\u00e9dicaments ne permettrait pas de g\u00e9n\u00e9rer un plus grand nombre d'ovocytes.<\/p>\n Dans certains cas, elle peut \u00e9galement \u00eatre pratiqu\u00e9e chez les patientes pr\u00e9sentant un bon pronostic et une r\u00e9serve ovarienne \u00e9lev\u00e9e.\u00a0Elle est utile aux couples ayant des difficult\u00e9s \u00e0 concevoir naturellement<\/strong>, permettant de surmonter les probl\u00e8mes de fertilit\u00e9 masculine et f\u00e9minine.<\/p>\n La FIV douce est une FIV o\u00f9 la stimulation ovarienne est r\u00e9alis\u00e9e au moyen d'un m\u00e9dicament favorisant le d\u00e9veloppement multifolliculaire (plus d'un ovule), mais d'une mani\u00e8re plus respectueuse du cycle naturel de la femme. Ce type de stimulation est appel\u00e9\u00a0stimulation douce<\/em>. Elle est indiqu\u00e9e chez les patientes pr\u00e9sentant une faible r\u00e9serve ovarienne, chez lesquelles l'utilisation de doses \u00e9lev\u00e9es de m\u00e9dicaments habituellement utilis\u00e9s en stimulation conventionnelle ne permettrait pas de g\u00e9n\u00e9rer un nombre d'ovocytes sup\u00e9rieur. Ainsi, ce type de stimulation permet d'obtenir des r\u00e9sultats \u00e9quivalents, voire sup\u00e9rieurs, \u00e0 ceux des cycles conventionnels, avec un confort accru pour les patientes et des co\u00fbts r\u00e9duits.<\/p>\n Le processus d\u00e9bute par une stimulation ovarienne par l'administration de faibles doses d'hormones (inducteurs d'ovulation et gonadotrophines) pendant 9 \u00e0 15 jours. Durant cette \u00e9tape, la patiente doit se rendre \u00e0 la clinique tous les 2 \u00e0 3 jours pour une \u00e9chographie de contr\u00f4le. Une fois les ovocytes matures, ils sont extraits par ponction ovarienne sous s\u00e9dation.<\/p>\n \u00c0 partir des ovocytes r\u00e9cup\u00e9r\u00e9s, le laboratoire g\u00e9n\u00e8re des embryons qui sont cultiv\u00e9s jusqu'au stade de blastocyste, g\u00e9n\u00e9ralement 5 \u00e0 6 jours apr\u00e8s la f\u00e9condation. L'embryon de meilleure qualit\u00e9 est s\u00e9lectionn\u00e9 pour \u00eatre transf\u00e9r\u00e9 dans l'ut\u00e9rus de la femme. Les embryons exc\u00e9dentaires sont congel\u00e9s en vue d'une nouvelle tentative de grossesse.<\/p>\n Dans certains cas, comme l\u2019\u00e9tude g\u00e9n\u00e9tique des embryons, tous les embryons g\u00e9n\u00e9r\u00e9s sont congel\u00e9s, le premier embryon \u00e9tant transf\u00e9r\u00e9 lors d\u2019un cycle ult\u00e9rieur.<\/p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font=”Unna||||||||” text_text_color=”#000000″ text_font_size=”26px” text_line_height=”1.6em” header_2_font=”Unna|700||on||||#000000|” header_2_text_color=”#000080″ header_2_font_size=”42px” header_2_line_height=”1.2em” header_4_font=”Unna|700|||||||” header_4_text_color=”#042C54″ header_4_font_size=”21px” custom_margin=”||||false|false” custom_margin_tablet=”||||false|false” custom_margin_phone=”||||false|false” custom_margin_last_edited=”on|phone” hover_enabled=”0″ text_font_size_tablet=”26px” text_font_size_phone=”20px” text_font_size_last_edited=”on|phone” header_2_font_size_tablet=”30px” header_2_font_size_phone=”30px” header_2_font_size_last_edited=”on|phone” global_colors_info=”{}” module_id=”Reception” sticky_enabled=”0″] contact<\/p>[\/et_pb_text][et_pb_contact_form captcha=”off” email=”info@humainhealthcare.com” submit_button_text=”Send Your Inquiry” _builder_version=”4.27.4″ _module_preset=”default” _unique_id=”ca5705d7-3205-4343-968c-c6a7ecdeb161″ form_field_background_color=”#FFFFFF” form_field_text_color=”#000000″ form_field_font=”Unna|–et_global_body_font_weight|||||||” form_field_font_size=”18px” custom_button=”on” button_text_color=”#FFFFFF” button_bg_color=”#000080″ button_border_width=”0px” button_font=”Unna|||on|||||” button_use_icon=”off” button_custom_margin=”15px|||23px|false|false” button_custom_margin_tablet=”15px|||23px|false|false” button_custom_margin_phone=”15px|||11px|false|false” button_custom_margin_last_edited=”on|phone” button_custom_padding=”12px|50px|12px|50px|true|true” width=”65%” width_tablet=”100%” width_phone=”100%” width_last_edited=”on|tablet” module_alignment=”center” custom_padding=”20px||||false|false” custom_padding_tablet=”20px||||false|false” custom_padding_phone=”0px||||false|false” custom_padding_last_edited=”on|phone” button_text_size_tablet=”” button_text_size_phone=”16px” button_text_size_last_edited=”on|phone” custom_css_free_form=”selector .et_contact_bottom_container{|| width: 100%;||}||||selector button{|| width: 100%;||}||||” border_width_all=”1px” locked=”off” global_colors_info=”{}”][et_pb_contact_field field_id=”First_Name” field_title=”First Name” _builder_version=”4.27.0″ global_colors_info=”{}” button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_contact_field][et_pb_contact_field field_id=”Last_Name” field_title=”Last Name” _builder_version=”4.27.0″ global_colors_info=”{}” button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_contact_field][et_pb_contact_field field_id=”Email” field_title=”Work Email Address” field_type=”email” _builder_version=”4.27.0″ global_colors_info=”{}” button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_contact_field][et_pb_contact_field field_id=”Phone” field_title=”Phone Number” allowed_symbols=”numbers” _builder_version=”4.27.4″ global_colors_info=”{}” button_text_size__hover_enabled=”off” button_one_text_size__hover_enabled=”off” button_two_text_size__hover_enabled=”off” button_text_color__hover_enabled=”off” button_one_text_color__hover_enabled=”off” button_two_text_color__hover_enabled=”off” button_border_width__hover_enabled=”off” button_one_border_width__hover_enabled=”off” button_two_border_width__hover_enabled=”off” button_border_color__hover_enabled=”off” button_one_border_color__hover_enabled=”off” button_two_border_color__hover_enabled=”off” button_border_radius__hover_enabled=”off” button_one_border_radius__hover_enabled=”off” button_two_border_radius__hover_enabled=”off” button_letter_spacing__hover_enabled=”off” button_one_letter_spacing__hover_enabled=”off” button_two_letter_spacing__hover_enabled=”off” button_bg_color__hover_enabled=”off” button_one_bg_color__hover_enabled=”off” button_two_bg_color__hover_enabled=”off”][\/et_pb_contact_field][et_pb_contact_field field_id=”What_is_your_inquiry_about?” field_title=”What is your inquiry about?” field_type=”text” fullwidth_field=”on” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_contact_field][\/et_pb_contact_form][\/et_pb_column][\/et_pb_row][\/et_pb_section]","protected":false},"excerpt":{"rendered":" Fertility Egg Vitrification Artificial Insemination with Partner Semen Artificial Insemination with Donor Semen In Vitro Fertilisation (IVF) Egg Reception IVF with Smart PGT-A Plus IVF with Smart PGT-M Plus IVF with Smart PGT-SR Plus Endometrial Preparation with Substituted Cycle Endometrial Preparation with Natural Cycle IVF with embryo prioritisation based on embryo genetics (EMBRACE) Time-lapse (EmbryoScope+\u2122) […]<\/p>","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"difl_page_category":[],"class_list":["post-889","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/humainhealthcare.com\/fr\/wp-json\/wp\/v2\/pages\/889","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/humainhealthcare.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/humainhealthcare.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/humainhealthcare.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/humainhealthcare.com\/fr\/wp-json\/wp\/v2\/comments?post=889"}],"version-history":[{"count":0,"href":"https:\/\/humainhealthcare.com\/fr\/wp-json\/wp\/v2\/pages\/889\/revisions"}],"wp:attachment":[{"href":"https:\/\/humainhealthcare.com\/fr\/wp-json\/wp\/v2\/media?parent=889"}],"wp:term":[{"taxonomy":"difl_page_category","embeddable":true,"href":"https:\/\/humainhealthcare.com\/fr\/wp-json\/wp\/v2\/difl_page_category?post=889"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}R\u00e9ception des \u0153ufs<\/strong><\/h2>\nLa r\u00e9ception d\u2019ovules est un traitement de procr\u00e9ation assist\u00e9e dans lequel les ovules d\u2019une donneuse sont\u00a0utilis\u00e9s pour \u00eatre f\u00e9cond\u00e9s avec le sperme du partenaire masculin ou d\u2019un donneur.\u00a0<\/strong>\n\nLes embryons obtenus sont transf\u00e9r\u00e9s dans l'ut\u00e9rus de la femme receveuse. Cette proc\u00e9dure convient aux femmes qui, pour diverses raisons m\u00e9dicales, ne peuvent pas utiliser leurs propres ovules.\n
Adoption d'embryons<\/strong><\/h2>\nL'adoption d'embryons, \u00e9galement appel\u00e9e\u00a0adoption d'embryons<\/strong>est une technique avanc\u00e9e de procr\u00e9ation assist\u00e9e qui offre aux couples et aux femmes c\u00e9libataires la possibilit\u00e9 de\u00a0recevoir des embryons donn\u00e9s de mani\u00e8re altruiste par d'autres couples.<\/strong>\n\nThese donated embryos are transferred into the uterus of the recipient, with the aim of achieving a successful pregnancy. Embryo donation is a viable option for those who face fertility problems and cannot use their own gametes (eggs and\/or sperm).\n\nIt is also\u00a0une alternative pour ceux qui pr\u00e9f\u00e8rent ne pas recourir au double don<\/strong>, i.e. the creation of embryos from scratch using donor eggs and sperm.\n\nThe aim of embryo reception is to provide viable embryos to people who cannot conceive with their own gametes.\n\nThe process begins with the selection of donated embryos, which have been previously cryopreserved after a successful in vitro fertilisation (IVF) cycle of another couple. The selected embryos are thawed and prepared for transfer to the recipient\u2019s uterus.\n\nThe woman who is to receive the embryo must prepare her uterus (endometrium) for the transfer. The doctor will indicate the best way to do this in her case. During the days of endometrial preparation, the woman will have to attend consultations to evaluate, by means of ultrasound, that the endometrium is in optimal conditions to receive an embryo.\n\nWhen the endometrium is optimal, the embryo is thawed and transferred to the uterus. This is a painless procedure in which the embryo is\u00a0positioned in the most suitable place in the uterus, guided by ultrasound.\n\nEmbryo transfer takes place at a stage of embryo development known as the blastocyst, which is reached approximately 5-6 days after fertilisation.\n\n\u00a0<\/strong>\n
FIV avec Smart PGT-A Plus<\/h2>\nLa FIV avec test g\u00e9n\u00e9tique pr\u00e9implantatoire pour l\u2019aneuplo\u00efdie (ou PGT-A) est une technique de procr\u00e9ation assist\u00e9e qui\u00a0analyse g\u00e9n\u00e9tiquement la constitution g\u00e9n\u00e9tique des embryons avant le transfert.<\/strong>\n\nElle permet de s\u00e9lectionner des embryons sains, ce qui am\u00e9liore les chances de grossesse \u00e9volutive. Elle est indiqu\u00e9e chez les couples ayant des ant\u00e9c\u00e9dents de\u00a0fausses couches \u00e0 r\u00e9p\u00e9tition<\/strong>\u00a0ou pr\u00e9sentant un risque chromosomique \u00e9lev\u00e9, ainsi que chez\u00a0les femmes de plus de 37 ans<\/strong>\u00a0or in case of genetic alterations in the sperm. It has a 60-70% success rate per transfer.\n\nIVF with PGT-A is an assisted reproductive treatment in which embryos are generated and, once generated, are genetically tested to find out whether they have a chromosomal abnormality. For this purpose, an IVF treatment is carried out, with ovarian stimulation and subsequent oocyte retrieval. Embryos generated from these oocytes and left in culture. When these embryos reach the blastocyst stage, an embryo biopsy is performed for carrying out the genetic study.\n\nIn this treatment, once the chromosomally normal embryo is obtained (euploid), the uterus is prepared for placement (embryo transfer). After obtaining a euploid embryo, the rate of gestation by embryo transfer is 60-70%.\n\nDifficulties with this treatment are due to advanced maternal age and low ovarian reserve. For this reason, in some cases, your doctor may recommend embryo banking.\n\nAt Fertty, we use Smart PGT-A plus technology, which provides ample information compared to other PGT-A technologies. In addition to being able to detect alterations in the number of chromosomes (and parts of chromosomes), it can also detect whether there is an extra or missing endowment of the whole chromosome set, known as ploidy alteration. But in addition to the extended diagnosis, this analysis can detect contamination in the samples analysed and allows us to confirm the kinship between embryos, which adds to the safety and reliability of the test.\n\n\u00a0<\/strong>\n
FIV avec Smart PGT-M Plus<\/h2>\nTest g\u00e9n\u00e9tique pr\u00e9implantatoire pour les maladies monog\u00e9niques<\/strong>\nLa FIV avec\u00a0test g\u00e9n\u00e9tique pr\u00e9implantatoire pour les maladies monog\u00e9niques<\/strong>\u00a0(ou PGT-M) est une technique de procr\u00e9ation assist\u00e9e qui teste g\u00e9n\u00e9tiquement les embryons avant leur transfert.\n\nElle permet de s\u00e9lectionner des embryons sains<\/strong>, which prevents the birth of a baby with a genetic disease inherited from its parents.\n\nIt is indicated for women or couples carrying genetic mutations that cause an inherited disease. It has a success rate of 60-70% per transfer.\n\nThis assisted reproduction treatment begins with a review by an ethics committee and a prior informativity study to ensure that the mutations responsible for the genetic disease can be detected with current techniques.\n\nOnce the method for diagnosis has been confirmed, embryos are created and tested for the genetic mutations associated with the disease. For this, IVF treatment is performed, which includes ovarian stimulation and egg retrieval. These eggs are fertilised in the laboratory, and the resulting embryos are cultured until they reach the blastocyst stage. At this point, a biopsy is performed to study their genetic make-up. In addition to checking for the presence of the disease-causing mutation, we also analyse all the chromosomes of the embryo to ensure that there are no other abnormalities affecting its viability. To do this, we combine the PGT-M study with the Smart PGT-A Plus technology, which offers more complete information than other PGT-A tools.\n\nWhen a healthy embryo is found, the uterus is prepared for transfer. In cases where the embryo does not have the disease and its chromosomes are normal, the pregnancy success rate is 60-70%. However, in situations such as advanced maternal age or a low ovarian reserve, it can be difficult to obtain a healthy embryo, so it is sometimes recommended to accumulate several embryos.\n\n\u00a0<\/strong>\n
FIV avec Smart PGT-SR Plus<\/h2>\n\nTest g\u00e9n\u00e9tique pr\u00e9implantatoire pour les r\u00e9arrangements structurels<\/strong>\n\nIVF with preimplantation genetic study of\u00a0structural rearrangements\u00a0(or PGT-SR) is an assisted reproductive technique that genetically analyses embryos before transfer.\n\nIt helps to select healthy embryos, which improves the chances of evolutionary pregnancy.\n\nIl est indiqu\u00e9 chez les personnes pr\u00e9sentant un r\u00e9arrangement chromosomique du caryotype.<\/strong>\n\nIt has a success rate of 60-70% per transfer.\n\nIn this assisted reproduction treatment, embryos are created and undergo genetic analysis to check for any chromosomal abnormalities. This is done by IVF treatment, which involves stimulation of the ovaries and subsequent egg retrieval. The eggs are fertilised in the laboratory and the resulting embryos are cultured until they reach the blastocyst stage. At this point, a biopsy is performed to study their genetic make-up.\n\nWhen a chromosomally normal (euploid) embryo is obtained, the uterus is prepared for embryo transfer. If the embryo is euploid, the chances of pregnancy by transfer are 60-70%. However, in cases such as advanced maternal age or low ovarian reserve, obtaining a healthy embryo may be more difficult, so the doctor may recommend cumulating several embryos.\n\nAt Fertty we use Smart PGT-SR Plus technology, which provides more detailed information than other testing methods. It detects alterations in chromosome number, but also if there is an extra or missing set of chromosomes (known as ploidy alteration). In addition, this analysis is able to detect possible contaminations in the samples and confirm kinship of the embryos, which provides extra security and accuracy in the results.\n\n\u00a0<\/strong>\n
Pr\u00e9paration endom\u00e9triale avec cycle substitu\u00e9<\/h2>\nLa pr\u00e9paration de l'endom\u00e8tre est un\u00a0processus essentiel dans les traitements de procr\u00e9ation assist\u00e9e<\/strong>, which aims at preparing the endometrium (the inner layer of the uterus) to receive an embryo and favour its implantation.\n\nIt is used in cases where the\u00a0Elle est utilis\u00e9e dans les cas o\u00f9 l' embryon a d\u00e9j\u00e0 \u00e9t\u00e9 g\u00e9n\u00e9r\u00e9 lors d'un cycle pr\u00e9c\u00e9dent (transfert d'embryons cryoconserv\u00e9s), lors de la r\u00e9ception d'embryons donn\u00e9s ou lors de la g\u00e9n\u00e9ration d'embryons \u00e0 partir d'un cycle de don d'ovules synchrone.<\/strong>\u00a0(cryopreserved embryo transfer), in the reception of donated embryos, or in the generation of embryos from a synchronous egg donation cycle.\n\nThis procedure can be performed using different approaches, depending on the individual needs of each patient.\n\nIn case of Substitute Cycle preparation, external hormones are used to prepare the endometrium.\n\nThis method is ideal for women with irregular cycles, who do not ovulate, or require a more precise treatment schedule.\n\n \n
FIV avec priorisation des embryons bas\u00e9e sur la g\u00e9n\u00e9tique des embryons (EMBRACE)<\/span><\/strong><\/h2>\nLa pr\u00e9paration de l'endom\u00e8tre est un processus fondamental dans les traitements de procr\u00e9ation assist\u00e9e, qui vise \u00e0 pr\u00e9parer l'endom\u00e8tre (la couche interne de l'ut\u00e9rus) \u00e0 recevoir un embryon et\u00a0\u00e0 favoriser son implantation.\u00a0<\/strong>\n\nElle est utilis\u00e9e dans\u00a0les cas o\u00f9 l'embryon a d\u00e9j\u00e0 \u00e9t\u00e9 g\u00e9n\u00e9r\u00e9 lors d'un cycle pr\u00e9c\u00e9dent<\/strong>\u00a0(cryopreserved embryo transfer), in the reception of donated embryos, or in the generation of embryos from a synchronous egg donation cycle.\n\nThis procedure can be performed using different approaches, depending on the individual needs of each patient.\n\nIn the case of the Natural Cycle preparation, the woman\u2019s own menstrual cycle and therefore her endogenous hormones are used to prepare the endometrium.\n\nThis approach is suitable for women with regular cycles. It is more comfortable as no medication has to be taken, but because it depends on the woman\u2019s cycle, we cannot schedule the procedures in advance.\n\n \n
FIV avec priorisation des embryons bas\u00e9e sur la g\u00e9n\u00e9tique des embryons (EMBRACE)<\/strong><\/h2>\nDans les cas o\u00f9 une bonne r\u00e9ponse \u00e0 la stimulation et un nombre \u00e9lev\u00e9 d\u2019embryons sont attendus, nous proposons la technique Embrace,\u00a0un puissant syst\u00e8me de priorisation bas\u00e9 sur la g\u00e9n\u00e9tique des embryons.<\/strong>\n\nDNA released into the culture medium enables us to obtain probability that the embryos are normal.\n\nThus,\u00a0nous transf\u00e9rons d\u2019abord les embryons ayant le plus grand potentiel<\/strong>, reducing the time needed to achieve an evolutionary pregnancy.\n\nIn this\u00a0assisted reproduction treatment, embryos are generated and, once the embryo culture phase is completed, the culture medium in which the embryos have developed is analysed.\n\nThis technology is based on the fact that embryos release part of their DNA to the outside. By studying this genetic material, we can infer the chromosomal status of the embryo, i.e. the probability that this embryo is chromosomally normal. It enables us to obtain this information without needing to manipulate the embryo by performing an embryo biopsy, as would be the case in PGT-A.\n\nFor this purpose, an IVF treatment is performed, where ovarian stimulation and subsequent oocyte retrieval is carried out. Embryos are generated from these oocytes, which develop in culture individually. When the embryos reach the blastocyst stage, they are vitrified and the culture media are then collected. These media will be analysed to obtain a prioritisation\u00a0score\u00a0<\/em>for embryo transfer.\n\nOnce the\u00a0score\u00a0<\/em>obtenu, l'ut\u00e9rus est pr\u00e9par\u00e9 pour le placement (transfert d'embryon) de l'embryon pr\u00e9sentant la plus forte probabilit\u00e9 d'\u00eatre euplo\u00efde, c'est-\u00e0-dire ne pr\u00e9sentant pas d'alt\u00e9rations chromosomiques, ce qui est corr\u00e9l\u00e9 \u00e0 la probabilit\u00e9 d'une grossesse \u00e9volutive. Chez les embryons pr\u00e9sentant le score le plus \u00e9lev\u00e9, c'est-\u00e0-dire ceux pr\u00e9sentant la plus forte probabilit\u00e9 d'\u00eatre chromosomiquement normaux, on estime un taux de gestation de 60 \u00e0 70 % par transfert.\u00a0score,\u00a0<\/em>i.e. those with the highest probability of being chromosomally normal, a gestation rate of 60-70% per transfer is estimated.\n\n \n
Time-lapse (EmbryoScope+\u2122) et s\u00e9lection d'embryons par intelligence artificielle (iDAScore\u2122)<\/strong><\/h2>\nDans les cas o\u00f9 une bonne r\u00e9ponse \u00e0 la stimulation ovarienne ou \u00e0 la FIV avec des ovules de donneuse est attendue, nous proposons la culture d'embryons en incubateur avec syst\u00e8me time-lapse\u00a0(EmbryoScope+\u2122)<\/strong>\u00a0et la s\u00e9lection d'embryons par intelligence artificielle\u00a0(iDAScore\u2122)<\/strong>.\n\nThis innovative tool\u00a0nous aide \u00e0 s\u00e9lectionner le meilleur embryon<\/strong>\u00a0to transfer first and thus achieve gestation in the shortest possible time.\n\nIn this assisted reproduction treatment, time-lapse technology is incorporated in the culture of the embryos generated in vitro and artificial intelligence for their selection.\n\nFor this, an IVF treatment is performed, either with the patient\u2019s own eggs or donor eggs. Once the eggs have been extracted, they are inseminated with the seminal sample of the couple or of a donor. From this moment on, the embryos are introduced into an incubator with a time-lapse system (EmbryoScope+TM). This technology allows us to obtain images of the entire embryonic development, which translates into more information on the evolution of each embryo and fewer environmental changes, since it is not necessary to remove the embryos from the incubator for their evaluation.\n\nWhen the embryos reach the blastocyst stage, we use the iDAScore\u2122 artificial intelligence software, which provides us with a score for each embryo within its cohort.\n\nThe advantage of using artificial intelligence is that the system is able to analyze a large number of morphological and kinetic characteristics of the embryo and correlates them with implantation and evolutionary gestation data much faster than traditionally.\nThe embryo with the highest score will be the first to be transferred into the maternal uterus and the rest will be vitrified. Future embryo transfers will follow the order of prioritization provided by the artificial intelligence system.\n\n \n
Activation ovarienne avec du plasma riche en plaquettes (PRP)<\/strong><\/h2>\nL'activation ovarienne par plasma riche en plaquettes (PRP) est une\u00a0technique innovante destin\u00e9e principalement aux patientes pr\u00e9sentant une faible r\u00e9serve ovarienne<\/strong>. Son objectif est d'augmenter le nombre d'ovocytes obtenus apr\u00e8s un cycle de stimulation ovarienne en vue d'une f\u00e9condation in vitro (FIV). Ce proc\u00e9d\u00e9 repose sur le pr\u00e9l\u00e8vement d'un \u00e9chantillon sanguin de la patiente, \u00e0 partir duquel est obtenue une fraction\u00a0de plasma riche en plaquettes<\/strong>\u00a0fraction is obtained which, after specific preparation, is injected directly into the ovaries.\n\nAlthough the technique of ovarian activation with PRP shows potential, it is\u00a0encore consid\u00e9r\u00e9e comme exp\u00e9rimentale<\/strong>. Currently, there is not enough data available to provide accurate success rates, suggesting that more research is needed to determine its potential benefit.\n\nTreatment with ovarian PRP aims to increase the number of oocytes recovered after ovarian stimulation for IVF in women with low ovarian reserve and, therefore, improve the prognosis of their treatment.\n\nThe most suitable profile for this treatment is that of a patient with an ovarian reserve of no more than approximately 8 oocytes and aged under 40 years. Indeed, this treatment does not manage to improve the quality of the oocytes obtained and, therefore, can be a good strategy to address low ovarian reserve but not age-related loss of oocyte quality.\n\nThe treatment procedure is as follows: once established that the patient qualifies for PRP treatment, a blood test to measure anti-M\u00fcllerian hormone (AMH) levels and an ultrasound scan to perform an antral follicle count (AFR) should be performed. This will allow subsequent assessment of the response to treatment. On the day of the PRP, the patient is scheduled for a peripheral blood draw. This blood sample will be processed according to a standardised protocol to separate the platelet-rich plasma fraction from the rest of the blood components. A few hours later, the patient will be escorted to the operating theatre where she will be prepared in the same way as for a follicular puncture procedure to retrieve oocytes. An anaesthetic technique of sedation will be used so that the patient does not feel any pain and, by means of ultrasound visualisation and the use of an ovarian puncture needle, previously activated PRP will be injected into the ovaries.\n\nAfter the intervention, an analytical follow-up with AMH determination and ultrasound with RFA will be performed to assess response to treatment. When indicated, ovarian stimulation may be initiated to recover oocytes for IVF.\n\nBear in mind that, as this is a technique that uses biological material obtained from the patient herself, it is considered to have a very low risk of adverse effects. It should also be noted that this is an experimental technique, which makes it difficult to estimate the extent of the treatment and that it may not have any effect at all.\n\n\u00a0<\/strong>\n
Enrichissement de l'endom\u00e8tre<\/strong><\/h2>\n\nTraitement de l'endom\u00e8tre par plasma riche en plaquettes (PRP)<\/strong>\n\nLe traitement de l'endom\u00e8tre par plasma riche en plaquettes (PRP) est une\u00a0technique innovante destin\u00e9e principalement aux patientes pr\u00e9sentant un endom\u00e8tre fin et\/ou pr\u00e9sentant des \u00e9checs d'implantation r\u00e9currents.<\/strong>\u00a0Its objective is to increase the thickness of the endometrium and\/or improve its receptivity in order to favour embryo implantation.\n\nThe process begins with the collection of a\u00a0\u00e9chantillon sanguin de la patiente,<\/strong>\u00a0\u00e0 partir duquel une fraction plasmatique riche en plaquettes est obtenue gr\u00e2ce \u00e0 un proc\u00e9d\u00e9 de pr\u00e9paration sp\u00e9cifique. Le PRP est ensuite administr\u00e9 dans l'endom\u00e8tre en plusieurs s\u00e9ances.\n\nLe PRP est pr\u00e9par\u00e9 en une seule journ\u00e9e<\/strong>\u00a0and the sample is kept frozen. Subsequently, the different plasma fractions are thawed and administered during the patient\u2019s endometrial preparation for embryo transfer.\n\nEndometrial PRP treatment aims to increase endometrial thickness and\/or quality in patients with thin endometrium and\/or a diagnosis of recurrent implantation failure. This treatment is especially aimed at patients in whom an adequate endometrial thickness is not achieved despite having applied different oestrogen administration protocols and\/or in those patients who have undergone several good quality embryo transfers without resulting in pregnancy.\n\nOnce established that the woman qualifies for endometrial PRP treatment, she is scheduled for preparation, which consists of a peripheral blood draw. This blood sample will be processed according to a standardised protocol to separate the platelet-rich plasma fraction from the rest of the blood components and frozen in different fractions (the total number may vary depending on the total volume of plasma obtained).\n\nAfterwards, the patient will start the endometrial preparation for the embryo transfer according to the protocol determined by her doctor. During this same process, and taking advantage of the visits for ultrasound checks, the PRP will be administered at endometrial level as in an artificial insemination (AI) procedure. The patient will be placed in gynaecological position in the consultation room, a speculum will be used to visualise the cervix and, using an AI catheter, a previously thawed fraction of PRP will be introduced. This procedure does not require anaesthesia and is repeated a total of 3 times. From this point on, when the doctor considers the patient ready, the embryo transfer is scheduled according to the established protocol.\n\nBear in mind that, as this is a technique that uses biological material obtained from the patient herself, it is considered to have a very low risk of adverse effects. It should also be noted that, although an increase in endometrial thickness is not always achieved, the best results observed in patients with the aforementioned pathologies are thought to be due to a qualitative improvement at the molecular level in the endometrium.[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|phone” _builder_version=”4.27.4″ _module_preset=”default” background_color=”#f9f9f9″ custom_padding_tablet=”” custom_padding_phone=”0px||||false|false” locked=”off” global_colors_info=”{}”][et_pb_row custom_padding_last_edited=”on|phone” _builder_version=”4.27.0″ _module_preset=”default” custom_padding_tablet=”” custom_padding_phone=”||0px||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_font=”Unna|700||on|||||” text_text_color=”#000080″ text_font_size=”55px” text_line_height=”1.2em” text_orientation=”center” text_font_size_tablet=”55px” text_font_size_phone=”30px” text_font_size_last_edited=”on|phone” global_colors_info=”{}”]